Skip to content

A study to compare tablet Nifedipine and Injection Labetalol to treat severe high blood pressure in pregnancy

A study of efficacy of oral nifedipine and intravenous labetalol for acute hypertensive crisis in pregnancy A Randomised control trial - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/06/112065
Enrollment
60
Registered
2026-06-05
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O169- Unspecified maternal hypertension,unspecified trimester Health Condition 2: O169- Unspecified maternal hypertension,unspecified trimester

Interventions

Intervention1: NIFEDIPINE: Participants receive an oral capsule of 10 mg Nifedipine The dose is repeated every 30 min if the target blood pressure is not achieved A maximum of five doses total 50 mg c

Sponsors

S Nijalingappa medical college
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Singleton pregnancy with gestational age more than or equal to 28 weeks. Diagnosed with hypertension during pregnancy (gestational hypertension, preeclampsia, or eclampsia). Presenting with an acute rise in blood pressure more than or equal to 160/110 mmHg, regardless of prior antihypertensive treatment. Informed consent will be obtained from all participants (or relatives, if unconscious) to ensure ethical and voluntary participation

Exclusion criteria

Exclusion criteria: Pre-existing renal or liver disease (possible secondary hypertension). Pulmonary oedema (risk worsened by nifedipine). Asthma, obstructive lung disease, or cardiac conditions (contraindicated with labetalol). Known allergy to nifedipine or labetalol.

Design outcomes

Primary

MeasureTime frame
Time taken to achieve the target blood pressure less than or equal to 140 by 90 mmHg or a 20 to 25 percent reduction in mean arterial pressure from baselineTimepoint: Maternal monitoring of blood pressure post intervention every 30 minutes till the target BP or MAP is achieved and thereafter for a period of 48 hrs blood pressure will be checked before intervention after 30 minutes after 60 minutes after 90 minutes after 120 minutes after 180 minutes after intervention

Secondary

MeasureTime frame
To compare the efficacy of oral nifedipine & intravenous labetalol in lowering blood pressure during acute hypertensive crisis during pregnancy.Timepoint: blood pressure will be checked before intervention after 30 minutes after 60 minutes after 90 minutes after 120 minutes afte 180 minutes of intervention

Countries

India

Contacts

Public ContactDr Janani B

S Nijalingappa medical college and HSK hospital and research centre Bagalkot

dr.nagarathnakuntoji@gmail.com9845058371

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 29, 2026